Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

NCT00111462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Anemia
Non-Myeloid Malignancies
Cancer

Interventions

DRUG: Darbepoetin alfa

Sponsor

Amgen